Chronic and new anxiety tied to increased dementia risk

In a study published in the Journal of the American Geriatrics Society, both chronic and new anxiety were associated with an increased risk of dementia. However, where anxiety had resolved, there was no association with dementia risk.

The study included 2,132 individuals with an average age of 76 years who were participating in the Hunter Community Study in Australia and who were followed for an average of 10 years. The presence of chronic anxiety and new onset anxiety were associated with 2.8- and 3.2-times higher risks of having dementia, respectively. Even higher risks were seen in adults with anxiety before the age of 70 years. People whose anxiety resolved did not have a higher dementia risk than people without current or past anxiety.

While this sort of question cannot be subject to a randomized controlled trial, this prospective cohort study used causal inference methods to explore the role of anxiety in promoting the development of dementia. The findings suggest that anxiety may be a new risk factor to target in the prevention of dementia and also indicate that treating anxiety may reduce this risk."

Kay Khaing, MMed, corresponding author of the University of Newcastle

Source:
Journal reference:

Khaing, K., et al. (2024) The effect of anxiety on all-cause dementia: A longitudinal analysis from the Hunter Community Study. Journal of the American Geriatrics Society. doi.org/10.1111/jgs.19078.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cholinesterase inhibitors may slow cognitive decline in dementia with Lewy bodies